Article
Abnormal modulation of serum osteocalcin by dietary phosphate and 1,25-dihydroxyvitamin D3 in the hypophosphatemic mouse.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 1 Sept 1996
Tsuji H, Cawthorn C, Ecarot B
Abstract excerpt
We evaluated in normal and hypophosphatemic (Hyp) mice whether changes in serum levels of osteocalcin in response to dietary phosphate supplementation, parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) administration were related to perturbations in calcium phosphate homeostasis. In normal mice, serum osteocalcin levels were not altered by phosphate supplementation. In contrast, phosphate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
